PATH | VRL
Menu

Impact of the Introduction of Pneumococcal Conjugate Vaccination on Pneumonia in The Gambia: Population-Based Surveillance and Case-Control Studies

This article, published in The Lancet Infectious Diseases, assessed the impact and effectiveness of routine infant vaccination with pneumococcal conjugate vaccines (PCV) on pneumonia in children in The Gambia, a low-income country with a high burden of pneumonia. The authors conducted population-based surveillance and case control studies to measure the impact of PCV13, introduced in The Gambia in May 2011, on the incidence of World Health Organization-defined radiological pneumonia. Findings indicate that the introduction of PCV13 was associated with modest reductions in hospitalized cases of pneumonia and substantial reductions in severe pneumonia in young children four years after introduction.

Author: Mackenzie GA, Hill PC, Sahito SM, et al.

Published: 2017

» Visit web page (English)

(Located at www.thelancet.com)

Citation: Mackenzie GA, Hill PC, Sahito SM, et al. Impact of the Introduction of Pneumococcal Conjugate Vaccination on Pneumonia in The Gambia: Population-Based Surveillance and Case-Control Studies. The Lancet Infectious Diseases. 2017;Early Online Publication.

Resource types: Peer-reviewed journal

Diseases/vaccines: Pneumococcus

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Africa